RIVASTIGMINE TARTRATE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
33342-089 -
Package NDC
33342-089-06 -
Package NDC
33342-089-09 -
Package NDC
33342-089-12 -
Package NDC
33342-089-15 -
Application number
ANDA203148 -
SPL ID
3ac90f1e-d2a5-4645-972b-0d627e4cc860 -
SPL set ID
4364f6ef-a8da-4805-be0d-aabbe8ca2d21 -
UNII
9IY2357JPE -
RxCUI
312835 -
RxCUI
312836 -
RxCUI
314214 -
RxCUI
314215
What the source publishes
- Labeler
- Macleods Pharmaceuticals Limited
- Active ingredients
- RIVASTIGMINE TARTRATE
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "RIVASTIGMINE TARTRATE",
"splId": "3ac90f1e-d2a5-4645-972b-0d627e4cc860",
"labels": [
{
"setId": "4364f6ef-a8da-4805-be0d-aabbe8ca2d21",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4364f6ef-a8da-4805-be0d-aabbe8ca2d21",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4364f6ef-a8da-4805-be0d-aabbe8ca2d21"
}
],
"routes": [
"ORAL"
],
"labeler": "Macleods Pharmaceuticals Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-089-06) / 10 CAPSULE in 1 BLISTER PACK",
"package_ndc": "33342-089-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20140902"
},
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE (33342-089-09)",
"package_ndc": "33342-089-09",
"identifierStatus": "well-formed",
"marketing_start_date": "20140902"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-089-12) / 10 CAPSULE in 1 BLISTER PACK",
"package_ndc": "33342-089-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20140902"
},
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (33342-089-15)",
"package_ndc": "33342-089-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20140902"
}
],
"productId": "33342-089_3ac90f1e-d2a5-4645-972b-0d627e4cc860",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "33342-089",
"deaSchedule": null,
"genericName": "RIVASTIGMINE TARTRATE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RIVASTIGMINE TARTRATE",
"strength": "1.5 mg/1"
}
],
"applicationNumber": "ANDA203148",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140902",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0333342089090",
"0333342091093",
"0333342090096"
],
"unii": [
"9IY2357JPE"
],
"rxcui": [
"312835",
"312836",
"314214",
"314215"
],
"spl_set_id": [
"4364f6ef-a8da-4805-be0d-aabbe8ca2d21"
],
"manufacturer_name": [
"Macleods Pharmaceuticals Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:33342-089_3ac90f1e-d2a5-4645-972b-0d627e4cc860"